Recruiting Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies. NCT06812104 Conditions Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more Locations Kameda General Hospital — Kamogawa, Chiba, Japan University of Fukui Hospital — Yoshida, Fukui, Japan Kurume University Hospital — Kurume, Fukuoka, Japan Hokkaido University Hospital — Sapporo, Hokkaido, Japan View all 17 locations View more locations Show fewer locations Loading locations... View Trial Details
